NASDAQ:RPID

Rapid Micro Biosystems (RPID) Stock Price, News & Analysis

$0.89
-0.10 (-10.10%)
(As of 05/3/2024 ET)
Today's Range
$0.89
$0.96
50-Day Range
$0.86
$1.10
52-Week Range
$0.74
$1.19
Volume
173,143 shs
Average Volume
39,210 shs
Market Capitalization
$37.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Rapid Micro Biosystems MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.33% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.40mentions of Rapid Micro Biosystems in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.09) to ($1.03) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.61 out of 5 stars

Medical Sector

833rd out of 904 stocks

Analytical Instruments Industry

25th out of 29 stocks

RPID stock logo

About Rapid Micro Biosystems Stock (NASDAQ:RPID)

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

RPID Stock Price History

RPID Stock News Headlines

Q1 2024 Rapid Micro Biosystems Inc Earnings Call
Charles Payne Demystifies Options
When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Charles Payne Demystifies Options
When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Rapid Micro Biosystems (RPID) to Release Earnings on Friday
RPID Rapid Micro Biosystems, Inc.
Q4 2023 Rapid Micro Biosystems Inc Earnings Call
See More Headlines
Receive RPID Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/01/2024
Today
5/05/2024
Next Earnings (Estimated)
8/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:RPID
Fax
N/A
Employees
193
Year Founded
N/A

Profitability

Net Income
$-52,470,000.00
Net Margins
-232.99%
Pretax Margin
-232.85%

Debt

Sales & Book Value

Annual Sales
$22.52 million
Book Value
$2.78 per share

Miscellaneous

Free Float
29,578,000
Market Cap
$37.83 million
Optionable
Not Optionable
Beta
1.17
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Robert G. Spignesi Jr. (Age 54)
    CEO, President & Director
    Comp: $777.53k
  • Mr. Sean M. Wirtjes (Age 55)
    Chief Financial Officer
    Comp: $510.64k
  • Mr. John J. Addington Wilson (Age 56)
    Chief Operating Officer
    Comp: $512.94k
  • Michael Beaulieu C.F.A.
    Vice President of Investor Relations & Corporate Communications
  • Mr. Michael Wysocki
    Senior Vice President of Sales & Marketing
  • Ms. Victoria L. Vezina (Age 56)
    Chief Human Resources Officer
    Comp: $366.36k
  • Ms. Kristine Williams
    Senior Vice President of Research & Development and Product Management

RPID Stock Analysis - Frequently Asked Questions

How have RPID shares performed in 2024?

Rapid Micro Biosystems' stock was trading at $0.74 at the beginning of 2024. Since then, RPID stock has increased by 20.3% and is now trading at $0.89.
View the best growth stocks for 2024 here
.

Are investors shorting Rapid Micro Biosystems?

Rapid Micro Biosystems saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 57,900 shares, a drop of 27.9% from the March 15th total of 80,300 shares. Based on an average daily volume of 73,200 shares, the short-interest ratio is presently 0.8 days. Approximately 0.3% of the company's shares are sold short.
View Rapid Micro Biosystems' Short Interest
.

When is Rapid Micro Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 2nd 2024.
View our RPID earnings forecast
.

How were Rapid Micro Biosystems' earnings last quarter?

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) released its quarterly earnings data on Friday, March, 1st. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.05. The business had revenue of $6.34 million for the quarter, compared to the consensus estimate of $6.30 million. Rapid Micro Biosystems had a negative net margin of 232.99% and a negative trailing twelve-month return on equity of 39.02%. During the same period last year, the firm earned ($0.39) EPS.

What guidance has Rapid Micro Biosystems issued on next quarter's earnings?

Rapid Micro Biosystems updated its FY 2024 earnings guidance on Friday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $27.0 million-, compared to the consensus revenue estimate of $27.1 million.

When did Rapid Micro Biosystems IPO?

Rapid Micro Biosystems (RPID) raised $125 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,600,000 shares at a price of $18.00-$20.00 per share.

How do I buy shares of Rapid Micro Biosystems?

Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RPID) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners